Literature DB >> 12589007

Clinical advances in therapies targeting the interleukin-2 receptor.

A C Church1.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12589007     DOI: 10.1093/qjmed/hcg014

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


× No keyword cloud information.
  11 in total

1.  Clinical studies of thiazide-induced hyponatremia.

Authors:  Kai Ming Chow; Bonnie Ching-Ha Kwan; Cheuk Chun Szeto
Journal:  J Natl Med Assoc       Date:  2004-10       Impact factor: 1.798

Review 2.  Management of sight-threatening uveitis: new therapeutic options.

Authors:  Matthias D Becker; Justine R Smith; Regina Max; Christoph Fiehn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Targeting activated T cells: successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis.

Authors:  H U Scherer; G-R Burmester; G Riemekasten
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

Review 4.  Memory T-cell-specific therapeutics in organ transplantation.

Authors:  Andrew J Page; Mandy L Ford; Allan D Kirk
Journal:  Curr Opin Organ Transplant       Date:  2009-12       Impact factor: 2.640

5.  Identification of novel Interleukin-2 inhibitors through computational approaches.

Authors:  Sobia Ahsan Halim; Omer Mohamed Abdalla; M Ahmed Mesaik; Abdul Wadood; Zaheer ul-Haq; Maria Kontoyianni
Journal:  Mol Divers       Date:  2013-03-14       Impact factor: 2.943

Review 6.  Monoclonal antibodies for podocytopathies: rationale and clinical responses.

Authors:  Maddalena Marasà; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2009-06       Impact factor: 28.314

7.  Reduced progression of cardiac allograft vasculopathy with routine use of induction therapy with basiliximab.

Authors:  Ricardo Wang; Lidia Ana Zytynski Moura; Sergio Veiga Lopes; Francisco Diniz Affonso da Costa; Newton Fernando Stadler Souza Filho; Tiago Luiz Fernandes; Natália Boing Salvatti; José Rocha Faria-Neto
Journal:  Arq Bras Cardiol       Date:  2015-06-23       Impact factor: 2.000

8.  The correlation between serum E-selectin levels and soluble interleukin-2 receptors with relation to disease activity in localized scleroderma.

Authors:  Karolina Wodok-Wieczorek; Natalia Salwowska; Ewa Syguła; Aleksandra Wodok; Dominika Wcisło-Dziadecka; Katarzyna Bebenek; Beata Bergler-Czop; Ligia Brzezińska-Wcisło
Journal:  Postepy Dermatol Alergol       Date:  2018-11-13       Impact factor: 1.837

9.  The role of basiliximab in the evolving renal transplantation immunosuppression protocol.

Authors:  Paola Salis; Chiara Caccamo; Roberto Verzaro; Salvatore Gruttadauria; Mary Artero
Journal:  Biologics       Date:  2008-06

Review 10.  Mathematical Models of the Impact of IL2 Modulation Therapies on T Cell Dynamics.

Authors:  Kalet León; Karina García-Martínez; Tania Carmenate
Journal:  Front Immunol       Date:  2013-12-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.